Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.068
Neutral
RSI(14)
55.170
Neutral
STOCH(KDJ)(9,3,3)
60.452
Buy
ATR(14)
0.246
High Vlolatility
CCI(14)
165.486
Buy
Williams %R
15.556
Overbought
TRIX(12,20)
0.026
Sell
StochRSI(14)
100.000
Buy
Inmode Ltd
INMD14.620USD
+0.150+1.04%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
924.12MMarket Cap
6.94P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Inmode Ltd
Currency: USD Updated: 2025-12-26Key Insights
Inmode Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 78/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 16.80.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Inmode Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
8
analysts
Hold
Current Rating
16.800
Target Price
+16.99%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Inmode Ltd Highlights
StrengthsRisks
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Undervalued
The company’s latest PE is 6.94, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 33.37M shares, decreasing 50.57% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.15K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-26The current financial score of Inmode Ltd is 8.41, ranking 41/207 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 93.17M, representing a year-over-year decrease of 28.46%, while its net profit experienced a year-over-year decrease of 57.12%.
Score
Financials
10.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.87
Operational Efficiency
9.40
Growth Potential
7.56
Shareholder Returns
7.23
Inmode Ltd's Company Valuation
Currency: USD Updated: 2025-12-26The current valuation score of Inmode Ltd is 6.12, ranking 174/207 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 6.94, which is 205.22% below the recent high of 21.17 and 18.02% above the recent low of 5.69.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 78/207
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-26The current earnings forecast score of Inmode Ltd is 6.75, ranking 164/207 in the Healthcare Equipment & Supplies industry. The average price target for Inmode Ltd is 16.00, with a high of 21.00 and a low of 15.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
8
analysts
Hold
Current Rating
16.800
Target Price
+16.99%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
90
Total
4
Median
7
Average
Company name
Ratings
Analysts
Inmode Ltd
INMD
8
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-26The current price momentum score of Inmode Ltd is 5.53, ranking 175/207 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 14.89 and the support level at 14.16, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
14.450
Buy
MA10
14.444
Buy
MA20
14.405
Buy
MA50
14.584
Buy
MA100
14.705
Sell
MA200
14.906
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-26The current institutional shareholding score of Inmode Ltd is 5.00, ranking 111/207 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 52.80%, representing a quarter-over-quarter decrease of 36.78%. The largest institutional shareholder is James Simons, holding a total of 2.45M shares, representing 3.88% of shares outstanding, with 6.40% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Mizrahy (Moshe)
Kreindel (Michael)
DOMA Perpetual Capital Management, LLC
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.
Meitav Investment House Ltd
1
2
Risk Assessment
Currency: USD Updated: 2025-12-26The current risk assessment score of Inmode Ltd is 7.74, ranking 31/207 in the Healthcare Equipment & Supplies industry. The company's beta value is 2.14. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
2.14
VaR
+5.47%
240-Day Maximum Drawdown
+31.53%
240-Day Volatility
+41.05%
Return
Best Daily Return
60 days
+5.58%
120 days
+5.58%
5 years
+15.51%
Worst Daily Return
60 days
-3.93%
120 days
-3.93%
5 years
-19.97%
Sharpe Ratio
60 days
-0.17
120 days
-0.09
5 years
-0.08
Risk Assessment
Maximum Drawdown
240 days
+31.53%
3 years
+71.16%
5 years
+86.43%
Return-to-Drawdown Ratio
240 days
-0.27
3 years
-0.27
5 years
-0.13
Skewness
240 days
-0.88
3 years
-0.47
5 years
+0.04
Volatility
Realised Volatility
240 days
+41.05%
5 years
+55.52%
Standardised True Range
240 days
+3.48%
5 years
+10.85%
Downside Risk-Adjusted Return
120 days
-17.40%
240 days
-17.40%
Maximum Daily Upside Volatility
60 days
+25.33%
Maximum Daily Downside Volatility
60 days
+20.52%
Liquidity
Average Turnover Rate
60 days
+1.99%
120 days
+2.06%
5 years
--
Turnover Deviation
20 days
-7.90%
60 days
+9.15%
120 days
+12.76%
Peer Comparison
Healthcare Equipment & Supplies
Inmode Ltd
INMD
6.75 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Inmode Ltd?
The TradingKey Stock Score provides a comprehensive assessment of Inmode Ltd based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Inmode Ltd’s performance and outlook.
How do we generate the financial health score of Inmode Ltd?
To generate the financial health score of Inmode Ltd, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Inmode Ltd's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Inmode Ltd.
How do we generate the company valuation score of Inmode Ltd?
To generate the company valuation score of Inmode Ltd, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Inmode Ltd’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Inmode Ltd’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Inmode Ltd.
How do we generate the earnings forecast score of Inmode Ltd?
To calculate the earnings forecast score of Inmode Ltd, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Inmode Ltd’s future.
How do we generate the price momentum score of Inmode Ltd?
When generating the price momentum score for Inmode Ltd, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Inmode Ltd’s prices. A higher score indicates a more stable short-term price trend for Inmode Ltd.
How do we generate the institutional confidence score of Inmode Ltd?
To generate the institutional confidence score of Inmode Ltd, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Inmode Ltd’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Inmode Ltd.
How do we generate the risk management score of Inmode Ltd?
To assess the risk management score of Inmode Ltd, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Inmode Ltd’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Inmode Ltd.
